Johnson & Johnson · 2025 Q1
ReportedApr 15, 2025
Period endedMar 31, 2025
Rule of 40+19
Reported this quarter
Revenue
$21.89B
QoQ -2.8%
YoY +2.4%
EPS
$4.54
QoQ +222.0%
YoY +238.8%
Free Cash Flow
$3.66B
QoQ -32.5%
YoY +19.5%
Gross Margin
66.4%
QoQ -1.9 pp
YoY -3.1 pp
FCF Margin
16.7%
QoQ -7.4 pp
YoY +2.4 pp
P/E Ratio
18.0
QoQ -14.5%
YoY +92.9%
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 200406.
HTML
8-K results announcement
Filed Apr 15, 2025
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
108 KB
HTM
Exhibit EX-99.2
Exhibit 99.2 to the 8-K
597 KB
HTM
Exhibit EX-99.3
Exhibit 99.3 to the 8-K
4 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-Q quarterly report
Period ended Mar 30, 2025, filed Apr 23, 2025
ZIP
XBRL data bundle
Structured financial statements from the 10-Q
JSON
Company facts (XBRL)
Every figure JNJ has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for 2025 Q1, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings